Martha Crago, Vice-Principal, Research and Innovation (VP-RI), is pleased to announce the appointment of Dr. Roman Szumski to the role of Special Advisor to the VP-RI in Public and Life Science Policy and Business Development. His appointment will commence on January 17, 2022 for a two-year term.
Congratulations to Professor Maxime Cohen, co-director of the Bensadoun School of Retail Management’s retail innovation lab, for being awarded the SCALE AI Research Chair in Data Science for Retail. The five-year chair will use AI to encourage healthier food choices, re-use more goods via a circular economy, make small businesses more efficient by digitizing supply chains in emerging markets, and increase access to legal advice.
Seven CIHR funded projects at Â鶹AV and the Research Institute of the Â鶹AV Health Centre to investigate impacts of vaccine hesitancy, health-care shortages, work-life imbalance for children, youth, and families in the context of the COVID-19 pandemic.
Canada’s most prestigious French-language learned society announced the recipients of its research awards today, and two Â鶹AV professors are among the winners.
At its 77th virtual gala ceremony, the non-profit organization , l’Association francophone pour le savoir, awarded Â鶹AV Professor Michel Biron the Prix André-Laurendeau and Professor Susanne Lajoie the Prix Jeanne-Lapointe.
The Canadian Association of Physicists recognizes achievements for Â鶹AV professors across many branches of research in physics
Dear Healthy Brains, Healthy Lives Community,
For nearly two years, researchers and trainees have had to adjust to the new realities of remote teaching and learning, limited laboratory and facility access and have made a collective effort to protect each other by masking and social distancing. As Â鶹AV resumes in-person activities, we are optimistic that the worst of the pandemic is behind us; however, we are also aware that individual experiences during this time have varied considerably across members of our community.
International team including Â鶹AV researchers has discovered a new type of seismic event. The existence of these hydraulic fracturing-induced earthquakesÌýsupports a scientific theory that until now had not been sufficiently substantiated by measurements.
Research and Innovation (R+I) is pleased to announce the appointment of Carole Goutorbe as the Director of Sponsored Research. She beganÌýher new role on November 22.
A multidisciplinary team of researchers, including Â鶹AV's Scott Weichenthal, an Associate Professor in the Department of Epidemiology, Biostatistics, and Occupational Health,ÌýhasÌýbeen awarded tÌýfrom the Natural Sciences and Engineering Research Council of Canada (NSERC).
The Canadian Hydrogen Intensity Mapping Experiment fast radio burst (CHIME/FRB) team, which discovered more than 500 new fast radio bursts in the first year of the detector’s operations, will receive the 2022 .
Recognized for her ground-breaking advancements in the field of DNA nanotechnology and precision medicine to combat major diseases
Hanadi Sleiman, Professor in the Department of Chemistry and Tier 1 Canada Research Chair in DNA Nanoscience, has transformed the field of DNA nanotechnology and revolutionized precise medical treatments for major diseases, like cancer – and she has just earned national recognition for her research.
Ìý
Ìý
Ìý
Ìý
Ìý
Innovative food production technologies for edible crickets and microalgae launch two Â鶹AV student-led projects into the semifinals of the NASA/CSA Deep Space Food Challenge.
A new paper from researchers Jérôme Dockès Gaël Varoquaux and Jean-Baptiste Poline (Healthy Brains, Healthy Lives and NeuroDataScience ORIGAMI laboratory) explores generalization of machine learning algorithms using data from the and the impact of strategies to improve the performance of predicting biomarkers on new cohorts.
Multidisciplinary unit to focus on rise of ‘superbugs’ identified by WHO as a leading threat to global health, responsible for 700,000 annual deaths worldwide
October 20, 2021 (Montreal, Quebec) – Globally, Antimicrobial Resistance (AMR) causes approximately 700,000 deaths annually, a number projected to reach over The prevalence of AMR in Canada is projected to reach 40% by this time, a plausible scenario if no interventions successfully curb their rise.